Clinical trials for personalized dose finding

MaRDI QIDQ2829305zbMATH OpenFDO

Authors Guanhua Chen, Donglin Zeng

Publication date 27 October 2016

zbMATH Keywords

clinical trialsoptimal treatment dose identification

Mathematics Subject Classification ID

Classification and discrimination; cluster analysis (statistical aspects) (62H30) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Recommendations

• Patient-specific dose finding in phase I clinical trials
• The treatment versus experimentation dilemma in dose finding studies
• Individualized dosing for multiple ordered groups of patients
• Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials
• Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates

Cited in

(5)

• Individualized dosing for multiple ordered groups of patients
• A utility approach to individualized optimal dose selection using biomarkers
• Overcoming inefficiencies in the development of personalized medicine
• Personalized medicine -- optimized EPO dosing
• Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates

This page was built for publication: Clinical trials for personalized dose finding

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2829305)